Studies have demonstrated that GHK-Cu can enhance cognitive performance and provide neuroprotection
[25] Chakravarthi S, Jessop CE, Bulleid NJ
No human study has used the subcutaneous route, and nobody has compared near-injury against distal injection in any species, so the direction comes from the human record rather than from a comparison that has been run
All work is non-clinical and mechanistic in nature
Research has explored its effects on: Fibroblast migration Collagen production and organization Angiogenesis Vascular endothelial growth factor Nitric-oxide signaling Growth-factor pathways Cellular survival Inflammatory mediators Gastrointestinal mucosal protection Tendon-to-bone healing Nerve and blood-vessel regeneration Rather than acting like a traditional pain reliever, BPC-157 is primarily researched for its potential influence on the biological environment surrounding injured tissue
The Clinical-Data Gap Is the Real Story The most important practical difference is the maturity and strength of the clinical evidence: Semaglutide and tirzepatide have extensive, robust human clinical trial data demonstrating significant metabolic effects they are among the most studied metabolic peptides in existence